196 Episodo

  1. EP 96: CEO of Montai Health, Margo Georgiadis, talks the intersection of nature and AI

    Publicado: 13/4/2023
  2. EP 95: Resharing Eric Topol on how Machine Learning & AI can Contribute to the Future of Healthcare

    Publicado: 31/3/2023
  3. EP 94: Alnylam’s Dr Paul Nioi on how genetics is used in drug target discovery

    Publicado: 16/3/2023
  4. EP 93: International Perspectives on Access to Genetic Testing in ALS

    Publicado: 24/1/2023
  5. EP 92: Four Predictions for 2023

    Publicado: 5/1/2023
  6. EP 91: 2022 Genetics Round-up with Dr Veera Rajagopal

    Publicado: 24/12/2022
  7. EP 90: Patient-centric drug development in ALS with Ronald van der Geest, Chief Development Officer of Treeway

    Publicado: 8/12/2022
  8. EP 89: Baroness Nicola Blackwood on the UK's leading role in delivering 'genomic healthcare for everyone'

    Publicado: 24/11/2022
  9. EP 88: Precision oncology: how Next Generation Sequencing (NGS) is powering care today and the treatments of the future with Christine Ward (Takeda) and Geoff Oxnard (Foundation Medicine)

    Publicado: 10/11/2022
  10. EP 87: Representation Matters: Why equitable access and community engagement are critical in genetic research

    Publicado: 27/10/2022
  11. EP 86: Heidi Rehm PhD, Chief Genomics Officer at Massachusetts General Hospital on curating and collaborating genomic datasets to guide the future of diagnostic and clinical research

    Publicado: 13/10/2022
  12. EP 85: Dr Jessica Kissinger on large-scale parasite genomics and the power of multi-omic data

    Publicado: 29/9/2022
  13. EP 84: Mark Kotter, CEO, and Founder of bit.bio, on creating every cell type and kickstarting a cell therapy revolution

    Publicado: 1/9/2022
  14. EP 83: Daphne Koller, Founder & CEO of Insitro - Integrating machine learning and biology at scale to reimagine drug discovery

    Publicado: 11/8/2022
  15. EP 82: Lessons from the world's largest genomic datasets with Daniel MacArthur, Director of the Centre for Population Genomics.

    Publicado: 13/7/2022
  16. EP 81: Cracking the druggable genome with Dietrich Stephan, Founder and CEO of NeuBase Therapeutics

    Publicado: 29/6/2022
  17. EP 80: Rare disease genomics and the 'near-coding' genome with Nicky Whiffin, Group Leader at the Wellcome Centre for Human Genetics

    Publicado: 15/6/2022
  18. EP 79: The Unknown Causes of Kidney Disease Project with Michael Spigler, Vice President of Patient Support and Education at American Kidney Fund

    Publicado: 1/6/2022
  19. EP 78: From datasets to front-line healthcare; polygenic risk scores and genomic prediction with Prof Sir Peter Donnelly, CEO of Genomics PLC

    Publicado: 18/5/2022
  20. EP 77: The journey to novel gene therapies for hearing loss and balance disorders with Laurence Reid, CEO at Decibel Therapeutics

    Publicado: 4/5/2022

6 / 10

Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com

Visit the podcast's native language site